Claritev Corp
4 nominees · 4 ballot items.
Election of four Class III directors; Ratification of PricewaterhouseCoopers LLP as independent auditors for 2026; Advisory (non-binding) approval of named executive officer compensation (say-on-pay); Approval of an amendment to the 2020 Omnibus Incentive Plan to increase share reserve by 2,375,000 shares.
Follow how the vote landed and what changed on Claritev Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot4
- 1
Election of the four Class III director nominees
ManagementBoard: FORElection of four Class III nominees (Anthony Colaluca, Jr.; Michael S. Klein; Allen R. Thorpe; Dale A. White) to serve until the 2029 annual meeting.
- 2
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2026
ManagementBoard: FORRatify appointment of PwC as Claritev’s independent registered public accounting firm for fiscal year 2026.
- 3
Advisory vote to approve the compensation of our named executive officers (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation of named executive officers as disclosed in the proxy statement, including the Compensation Discussion and Analysis and executive compensation tables.
- 4
Approval of the Amendment to the Claritev Corporation 2020 Omnibus Incentive Plan
ManagementBoard: FORApprove an amendment increasing the share reserve under the 2020 Omnibus Incentive Plan by 2,375,000 shares to a total of 7,771,250 shares to permit continued granting of equity awards.
Nominees on the ballot4
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | H Corporate Investors VIII, Ltd. | 22.8% | 3,887,858 | $64M |
| 2 | ARES MANAGEMENT LLC | 10.9% | 1,863,105 | $30M |
| 3 | Arini Captial Management Ltd | 9.0% | 1,534,687 | $25M |
| 4 | PUBLIC INVESTMENT FUND | 7.5% | 1,281,250 | $21M |
| 5 | Beach Point Capital Management LP | 4.7% | 795,346 | $13M |
| 6 | CPV Partners, LLC | 2.9% | 495,258 | $8M |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 2.5% | 430,068 | $7M |
| 8 | CASPIAN CAPITAL LP | 2.1% | 356,250 | $6M |
| 9 | PRUDENTIAL FINANCIAL INC | 2.1% | 352,219 | $6M |
| 10 | BlackRock, Inc. | 2.0% | 340,352 | $6M |
Other Healthcare sector meetings6
Upcoming shareholder meetings at Claritev Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Claritev Corp 2026 annual meeting?
- Claritev Corp (CTEV) holds its 2026 annual shareholder meeting on Wednesday, April 29, 2026.
- What is the record date for the Claritev Corp 2026 meeting?
- The record date for the Claritev Corp 2026 meeting is Friday, March 6, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Claritev Corp's 2026 meeting?
- The board is presenting 4 director nominees at the Claritev Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Claritev Corp 2026 meeting?
- Shareholders will vote on 4 proposals at the Claritev Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.